Loading...
Monogram Orthopaedics, Inc.
MGRM•NASDAQ
Healthcare
Medical - Devices
$5.68
$-0.04(-0.70%)
Monogram Orthopaedics, Inc. (MGRM) Financial Performance & Income Statement Overview
Review Monogram Orthopaedics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-100.00%
↓ 100.00%
Operating Income Growth
11.34%
↑ 11.34%
Net Income Growth
-18.79%
↓ 18.79%
Operating Cash Flow Growth
-3.14%
↓ 3.14%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-126.44%
↓ 126.44%
ROIC
-112.37%
↓ 112.37%
Monogram Orthopaedics, Inc. (MGRM) Income Statement & Financial Overview
Review Monogram Orthopaedics, Inc.'s (MGRM) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $106846.00 | $105898.00 |
| Gross Profit | $0.00 | $0.00 | -$106846.00 | -$105898.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $1.74M | $2.21M | $2.43M | $2.41M |
| SG&A Expenses | $1.18M | $2.93M | $1.21M | $1.10M |
| Operating Expenses | $2.92M | $5.15M | $3.63M | $3.50M |
| Total Costs & Expenses | $2.92M | $5.15M | $3.63M | $3.61M |
| Interest Income | $213858.00 | $112621.00 | $96066.00 | $103455.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $108886.00 | $108370.00 | $106846.00 | $105898.00 |
| EBITDA | -$2.81M | -$5.04M | -$3.53M | -$3.50M |
| EBITDA Ratio | ||||
| Operating Income | -$2.92M | -$5.15M | -$3.63M | -$3.61M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | -$1.33M | $112621.00 | $96066.00 | $103455.00 |
| Income Before Tax | -$4.25M | -$5.03M | -$3.54M | -$3.51M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $2.00 |
| Net Income | -$4.25M | -$5.03M | -$3.54M | -$3.51M |
| Net Income Ratio | ||||
| EPS | $0.00 | -$0.16 | -$0.11 | -$0.11 |
| Diluted EPS | $0.00 | -$0.16 | -$0.11 | -$0.11 |
| Weighted Avg Shares Outstanding | $32.57M | $32.22M | $31.56M | $31.54M |
| Weighted Avg Shares Outstanding (Diluted) | $32.57M | $32.22M | $31.56M | $31.54M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan